Form 4: CEO Ronald Lombardi Adjusts Prestige Consumer Holdings

Sentiment:

Statement of Changes in Beneficial Ownership


Prestige Consumer Healthcare CEO Ronald M. Lombardi reported the vesting of performance units and a subsequent tax-related share disposition.

Summary

  • CEO Ronald M. Lombardi acquired 31,468 shares of common stock upon the settlement of performance stock units (PSUs) granted in 2023.
  • The reporting person disposed of 16,789 shares at a price of $55.31 per share to satisfy tax withholding obligations.
  • The CEO was granted an additional 19,662 restricted stock units (RSUs) vesting in three equal annual installments starting May 4, 2027.
  • Following these transactions, the CEO's total beneficial ownership stands at 378,205 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard executive compensation cycles rather than a shift in company performance or outlook.

Positives

  • Successful vesting of performance-based equity indicates achievement of pre-defined per-share growth goals.
  • Continued alignment of executive interests with shareholders through significant equity holdings.

Negatives

  • The disposition of 16,789 shares, while tax-related, reduces the immediate direct holdings of the CEO.

Risks

  • Future vesting of the newly granted 19,662 RSUs is subject to continued employment and time-based conditions.

Future Outlook

The CEO received a new grant of 19,662 restricted stock units that will vest in equal installments over the next three years, signaling long-term retention and incentive alignment.

Management Comments

  • The transactions reflect the settlement of performance stock units based on the achievement of per-share growth goals.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of executive compensation and tax management, common among mid-cap consumer healthcare firms, and does not signal a change in strategic direction.

Comparison to Industry Standards

  • The use of performance-based vesting for executive compensation is consistent with standard corporate governance practices in the consumer goods sector.
  • Tax-related share withholding is a standard mechanism for executives to manage the tax impact of equity vesting.

Stakeholder Impact

  • Shareholders may view the achievement of performance goals as a positive indicator of management's ability to drive growth.

Next Steps

  • Vesting of 6,554 shares on May 4, 2027.
  • Vesting of 6,554 shares on May 4, 2028.
  • Vesting of 6,554 shares on May 4, 2029.

Key Dates

DateDescription
05/05/2023Original grant date of the performance stock units that vested.
05/04/2026Date of transaction involving vesting and tax withholding.
05/06/2026Filing date of the Form 4.
05/04/2027First vesting date for the new RSU grant.

Keywords

Prestige Consumer Healthcare, PBH, Insider Trading, Form 4, Executive Compensation, Ronald Lombardi

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.